ViVac Appoints Keren Leshem as Chief Executive Officer, Strengthening Leadership to Advance RNA-Lipid Nanoparticle Immunotherapy Platform
ViVac Pharma appoints biotechnology leader Keren Leshem as CEO to accelerate the development of its breakthrough ...
Read moreDetails
